Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
REGEnLIFE tests light stimulation on neurodegenerative diseases
REGEnLIFE: a revolution in the treatment of neurodegenerative diseases

The Neuroprotective Effect Of A New Photobiomodulation Technique On Aβ25-35 Peptide-Induced Toxicity Dramatically Impacts Gut Microbiota Dysbiosis

12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019, San Diego

Guillaume Blivet, Laura Auboyer, Johann Meunier, Laura Ceolin, François J. Roman, Rémy Burcelin, Jacques Touchon.

Share this article